Hatsun Agro Product Q4 Results

  • BSE: 531531
  • NSE: HATSUN
  • ISIN: INE473B01035
  • Sector: Food Processing
BSE
1,12011.90 (1.07%)
Volume2.45 K
Updated: Tue 9 Jul, 2024 | 15:29:52
NSE
1,120.5512.45 (1.12%)
Volume24.27 K
Updated: Tue 9 Jul, 2024 | 15:29:57
Today: 1,108.10
1,125.00
52-Wk: 923.10
1,231.95

Technical Trends

Long Term
Considers price movement over the last 6 months

Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available
  • Bearish
  • Moderately Bearish
  • Neutral
  • Moderately Bullish
  • Bullish

Insight: Trends unavailable at the moment.

Q4 Results Highlights

  • Total Income
    ₹2,046.87 Cr.
    (14.38%)
  • Operating Profit
    ₹118.71 Cr.
    (94.88%)
  • Profit After Tax
    ₹52.16 Cr.
    (108.74%)
  • Operating Margin
    5.80%
    (70.37%)
Note: Comparison is on YoY basis

Quarterly - Hatsun Agro Product Q4 Results

*All figures in crores except per share values
Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
Total Revenue 2,046.871,695.178.44%1,789.4614.38%
Selling/ General/ Admin Expenses Total 60.4352.219.77%58.832.72%
Depreciation/ Amortization 110.8991.619.13%95.5116.10%
Other Operating Expenses Total 337.50266.4210.58%264.2327.73%
Total Operating Expense 1,928.161,596.658.54%1,728.5511.55%
Operating Income 118.7198.526.88%60.9194.88%
Net Income Before Taxes 70.8963.18-7.53%32.88115.59%
Net Income 52.1646.44-9.14%24.99108.74%
Diluted Normalized EPS 2.342.12-9.30%1.13107.87%

Hatsun Agro Product Q4 News

Q4 Results Today: Reliance, Mahindra Logistics among 22 companies to post Q4 earnings on April 22
1 min read22 Apr 2024
More From News

EQUITY QUICK LINKS

FROM MARKETS

RELATED LINKS

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe

      Trending Now In Market

      HomeMarketsPremiumInstant LoanMint Shorts

      Wait for it…

      Log in to our website to save your bookmarks. It'll just take a moment.

      Yes, Continue